USADA announced today that John Lorenz, of Fountain, Colo., an athlete in the sport of wrestling, has tested positive for a prohibited substance and accepted a suspension for his anti-doping rule violation.
A urine sample collected out-of-competition from Lorenz on July 10, 2011 contained Clomiphene, which is in the class of Hormone Antagonists and Modulators. Hormone Antagonists and Modulators are prohibited under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Federation of Associated Wrestling Styles (FILA) Anti-Doping Regulations, both of which have both adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Lorenz, 31, accepted a two-year period of ineligibility, which began on October 4, 2011, the day he accepted his sanction. As a result of the sanction, Lorenz is also disqualified from all competitive results obtained on and subsequent to July 10, 2011, the day the sample was collected, including forfeiture of any medals, points, and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.